Table 2.
Mean values of the neuroendocrine indices, FMS symptoms, and functions by group
| Normal (n=11) | Overweight (n=8) | Obese (n=19) | Correlation coefficients with BMI | |
|---|---|---|---|---|
| IL-6 (pg/mL) | 3.41 (1.09) | 3.28 (.78) | 4.35 (1.39) | 0.52 |
| Cortisol (μg/dL) | 8.77 (2.70) | 6.50 (3.29) | 9.35 (4.33) | 0.32 |
| Norepinephrine (pg/mL) | 476.00 (217.53) | 466.75 (221.37) | 509.21 (291.53) | 0.05 |
| Epinephrine (pg/mL) | 21.78 (13.70) | 20.25 (9.27) | 30.07 (17.41) | 0.54 |
| CRPa (mg/dL) | 0.18 (0.13) | 0.34 (0.25) | 0.73 (0.64) | 0.37 |
| TP counts | 17.72 (0.65) | 17.25 (2.12) | 17.84 (0.50) | 0.17 |
| TP severity | 5.41 (0.78) | 5.17 (1.99) | 5.52 (1.26) | 0.13 |
| FIQ disability | 1.40 (0.60) | 1.82 (0.47) | 1.44 (0.70) | 0.26 |
| FIQ pain | 76.91 (18.70) | 66.00 (17.42) | 69.74 (17.22) | −0.06 |
| FIQ fatigue | 74.27 (28.96) | 78.75 (16.94) | 85.53 (10.66) | 0.26 |
| FIQ AM not refreshed | 75.55 (20.57) | 83.00 (17.66) | 86.84 (10.64) | 0.27 |
| FIQ AM stiffness | 58.00 (34.33) | 84.50 (12.74) | 75.10 (17.32) | 0.22 |
| FIQ anxiety | 69.73 (25.88) | 79.63 (16.57) | 54.44 (27.99) | −0.19 |
| FIQ depression | 50.64 (24.90) | 55.25 (25.23) | 43.37 (28.04) | −0.03 |
| Walking distance (mile) | 0.71 (0.29) | 0.45 (0.25) | 0.47 (0.30) | −0.41 |
| Max heart rate | 100.50 (33.14) | 95.63 (14.58) | 116.56 (13.34) | 0.33 |
| Total sleep minutes | 427.21 (36.32) | 414.24 (40.23) | 391.57 (55.61) | −0.56 |
| Sleep efficiency (%) | 95.69 (2.08) | 91.93 (5.98) | 91.53 (4.30) | −0.44 |
| Sleep latency (min) | 9.63 (3.32) | 13.23 (9.05) | 16.43 (12.64) | 0.21 |
| Waking after sleep onset | 21.83 (10.52) | 39.48 (28.48) | 37.92 (17.80) | 0.36 |
| Activity index during sleep | 48.82 (11.87) | 54.48 (13.87) | 59.43 (13.35) | 0.41 |
a
n=6 for normal weight, n=5 for overweight, n=15 for obese